Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-890P is a *pseudogene* classified as a non-coding RNA related to the U6 small nuclear RNA (snRNA), part of the spliceosomal machinery in its functional form[1][2]. However, as a pseudogene, RNU6-890P does not encode a functional RNA product and is generally considered a genetic remnant without direct physiological or pharmacological relevance[1][2]. Pseudogenes such as RNU6-890P can occasionally have regulatory effects on gene expression, for instance by acting as miRNA sponges or generating regulatory RNA fragments, although there is no curated evidence in current databases for a specific biological or disease-linked function for RNU6-890P itself[4]. It is not considered a therapeutic target, and there are no known drugs or clinical biomarkers associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 890, pseudogene (RNU6-890P).